A high-level overview of BridgeBio Pharma, Inc. (BBIO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
View BridgeBio Pharma (BBIO) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. Trade commission-free with the Futubull stock trading app.
It’s exciting to consider the progress that BridgeBio Pharma might make in addressing achondroplasia and other conditions. Clearly, today’s financial traders are enthused about the prospects, as they’re quickly bidding up the price of BBIO stock. On the date of publication, David Moadeldid no...
2024 were $21.5 million, of which $4.9 million is included in R&D expenses, $16.5 million is included in SG&A expenses, and $0.1 million is included in Restructuring expenses. Stock-based compensation expenses included in operating costs and expenses for the same period in...
Stock-based compensation expenses included in operating costs and expenses for the three months endedSeptember 30, 2024were$27.1 million, of which$12.1 millionis included in R&D expenses,$15.0 millionis included in SG&A expenses, and less than$0.1 millionis included in restructuring, im...
which i also covered earlier. today bbio is trading at near $60, even after announcing a huge $650mn convertible debt offering, because it was finally able to acquire eidos. the completion of the merger has disrupted the stock's upward movement, and it seems to have fallen nearly 20%. ...
BridgeBio Pharma has an analyst consensus of Strong Buy, with a price target consensus of $74.44, implying a 13.8% upside from current levels. In a report issued on February 22, J.P. Morgan also initiated coverage with a Buy rating...
The Company closed an underwritten public offering of shares of its common stock with gross proceeds of approximately$150 million. First Quarter 2023 Financial Results:Cash, Cash Equivalents,Marketable Securitiesand Restricted Cash (Current) Cash, cash equivalents, marketable securities and res...